RxDoctor Payments Data

Jason Mammino

Dermatology · Castle Rock, CONPI 1548757073

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 92.8% of the total across 432 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 29 manufacturers reported payments, led by AbbVie at 25.9% of the total. 2025 is the largest year on record at $3,764, more than ten times the $125 reported in 2019.

$8,796in general payments, 2019–2025

Across 432 payments — averaging $20.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Johnson & Johnson$925
  • E.r. Squibb & Sons, L.L.C.$670
  • UCB, Inc.$664
  • Amgen$442
  • Regeneron Healthcare Solutions, Inc.$391
  • plus $3K from 23 others

What the payments were for

  • Food & beverage$8,16093%
  • Education$6357%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$8,796 in reported general payments places this provider in the 85th percentile of 280 dermatology providers in Colorado.

See all dermatology providers in Colorado

Medicare billing

Part B allowed, 2024
$314,338
Medicare patients
831
Services billed
5,257

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Clobetasol Propionate85$4,095
Ketoconazole115$2,298
Doxycycline Hyclate46$1,919
Triamcinolone Acetonide149$1,464
Betamethasone Dipropionate25$1,169
Fluorouracil17$1,122
Metronidazole19$765
Clindamycin Phosphate26$756
ValacyclovirValacyclovir Hcl31$497
Spironolactone32$343
Mupirocin40$304
Hydrocortisone30$178
Cephalexin11$80

Paid to pharmacies, not to this prescriber.

Other dermatology in Castle Rock

See the full list for Colorado

Where these figures come from

Is this you, or does something look wrong? →